Philina Lee

Corporate Officer/Principal chez BLUEPRINT MEDICINES CORPORATION

Fortune : 4 M $ au 31/05/2024

47 ans

Health Technology

Consumer Services

Finance

Postes actifs de Philina Lee

Sociétés	Poste	Début	Fin
BLUEPRINT MEDICINES CORPORATION	Corporate Officer/Principal	01/01/2021	-

Sociétés	Poste	Début	Fin
FUSN PHAR	Directeur/Membre du Conseil	11/02/2021	04/06/2024
FUSN PHAR	Independent Dir/Board Member	11/02/2021	04/06/2024
ALGETA ASA	Corporate Officer/Principal	-	-

University of Alberta	Undergraduate Degree
Massachusetts Institute of Technology	Doctorate Degree

Internationale

Opérationnelle

Corporate Officer/Principal	2
Undergraduate Degree	1
Director/Board Member	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
BLUEPRINT MEDICINES CORPORATION	Health Technology

Entreprise privées	2
Fusion Pharmaceuticals, Inc. Fusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.	Health Technology
Algeta ASA Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway.	Health Technology

Entreprise privées

Health Technology